Collaboration and License Agreements - Shenyang Sunshine Pharmaceutical Co., Ltd - Narrative (Details) - 3SBio License $ in Millions |
9 Months Ended |
|---|---|
|
Sep. 30, 2026
USD ($)
| |
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
| Aggregate amount of upfront and milestone-based payments | $ 7.0 |
| Aggregate amount for future payments upon achievement of clinical and regulatory approval milestones for products containing ImmTOR platform | $ 15.0 |